Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

BUY
$1.65 - $3.94 $7,197 - $17,186
4,362 New
4,362 $16,000
Q2 2023

Jul 18, 2023

BUY
$4.76 - $6.59 $8,134 - $11,262
1,709 Added 105.95%
3,322 $15,000
Q1 2023

Apr 13, 2023

SELL
$4.24 - $11.12 $163,015 - $427,530
-38,447 Reduced 95.97%
1,613 $9,000
Q4 2022

Jan 23, 2023

SELL
$9.86 - $23.83 $2.06 Million - $4.97 Million
-208,559 Reduced 83.89%
40,060 $0
Q3 2022

Oct 26, 2022

BUY
$21.04 - $36.06 $637,869 - $1.09 Million
30,317 Added 13.89%
248,619 $5.57 Million
Q2 2022

Jul 25, 2022

SELL
$17.78 - $42.39 $391,604 - $933,639
-22,025 Reduced 9.16%
218,302 $5.41 Million
Q1 2022

May 02, 2022

SELL
$29.67 - $60.28 $104,438 - $212,185
-3,520 Reduced 1.44%
240,327 $9.32 Million
Q4 2021

Jan 28, 2022

BUY
$47.84 - $64.34 $11.7 Million - $15.7 Million
243,847 New
243,847 $14.3 Million

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.